2004
DOI: 10.1111/j.1087-0024.2004.09115.x
|View full text |Cite
|
Sign up to set email alerts
|

The Burden of Psoriasis Is Not Determined by Disease Severity Only

Abstract: Psoriasis is a chronic scaling and inflammatory skin disease that can affect patients' quality of life and daily functioning. We studied the scores of 85 patients suffering from moderate to severe plaque-type psoriasis, participating in a randomized controlled trial. We compared their scores on a generic quality-of-life instrument with data from two reference populations. We examined associations between clinical severity, as measured by the components of the Psoriasis Area and Severity Index (PASI), and the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
107
2
4

Year Published

2005
2005
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 124 publications
(122 citation statements)
references
References 15 publications
9
107
2
4
Order By: Relevance
“…Clinical severity as measured by the SAPASI had an important role especially in the IPSO question, which is different in that it includes different aspects of sexual life, such as ‘feeling physically unattractive’, compared to the other questions. Taken together, these results confirm the important issue that the different aspects of quality of life in psoriasis are not only associated with physical manifestations and clinical severity [8, 18], and that the association of quality of life impairment and psychological morbidity is very strong. Also, the questions concerning sexual life correlated with all the other questions concerning social relationships, as expected, but they were not particularly correlated with symptoms.…”
Section: Discussionsupporting
confidence: 76%
See 1 more Smart Citation
“…Clinical severity as measured by the SAPASI had an important role especially in the IPSO question, which is different in that it includes different aspects of sexual life, such as ‘feeling physically unattractive’, compared to the other questions. Taken together, these results confirm the important issue that the different aspects of quality of life in psoriasis are not only associated with physical manifestations and clinical severity [8, 18], and that the association of quality of life impairment and psychological morbidity is very strong. Also, the questions concerning sexual life correlated with all the other questions concerning social relationships, as expected, but they were not particularly correlated with symptoms.…”
Section: Discussionsupporting
confidence: 76%
“…The desquamation scores obtained by the SAPASI were grouped into two classes: one regrouping scores 0, 1 and 2 (none, slight, and moderate desquamation), and the other regrouping the scores 3 and 4 (severe and extraordinarily severe desquamation). We chose to analyze the desquamation component of clinical severity, because it has been shown to be the one more associated with some components of quality of life and psychological well-being [18]. …”
Section: Methodsmentioning
confidence: 99%
“…Children with AD had the quality of life inversely correlated with disease severity evaluated by Children's Dermatology Life Quality Index (CDLQI) and SCORAD, especially in the first visits 29 . The discrepancy of our data in suggesting some specific grouping in the sample was also suggested by others, specially in psoriasis when objective Psoriasis Area Severity Index(PASI) is evaluated, without correlation with QoL self assessment 32 . This correlation was attributed to some subgroups present in low numbers in the whole population which affect the main response of the sample.…”
contrasting
confidence: 79%
“…Comparatively high acquisition costs of these new agents however evoked a debate about their appropriate use [12]. This is one reason why pharmacoeconomic analyses have recently gained more interest in the dermatological literature [13,14,15,16,17,18]. Guidelines for pharmacoeconomic studies recommend to use the societal perspective, which means that direct and indirect costs of disease need to be considered [19,20,21,22].…”
Section: Introductionmentioning
confidence: 99%